Promotion of microtubule assembly in vitro by taxol
The DOI matches its Crossref record; 18 of the 18 references it cites were found in a registry or an index.
Overview
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“PTX is a member of taxanes family, which arrest cells in the G2/M phase by binding to the β-tubulin subunits, inhibiting depolymerization of microtubules and cause apoptosis through cell-signaling cascades [3].”
In the citing paper
“The binding of paclitaxel counters the conformational effect of GTP-hydrolysis on microtubules, stabilizing microtubules against depolymerization.69,70”
From Electronic energy migration in microtubules (2023) · cites this paper as [69]
Citations
Cites
PROTEIN MEASUREMENT WITH THE FOLIN PHENOL REAGENT
Lowry, O., Rosebrough, N., Farr, A. L., & Randall, R. (1951) · Journal of Biological Chemistry · doi:10.1016/s0021-9258(19)52451-6 · Cited by 317,331
Wani, M. C., Taylor, H. L., Wall, M. E., Coggon, P., & McPhail, A. T. (1971) · Journal of the American Chemical Society · doi:10.1021/ja00738a045 · Cited by 4,073
A protein factor essential for microtubule assembly
Weingarten, M. D., Lockwood, A. H., Hwo, S. Y., & Kirschner, M. W. (1975) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.72.5.1858 · Cited by 3,089
Microtubule Assembly in the Absence of Added Nucleotides
Shelanski, M. L., Gaskin, F., & Cantor, C. R. (1973) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.70.3.765 · Cited by 2,053
Microtubule Formation in vitro in Solutions Containing Low Calcium Concentrations
Weisenberg, R. C. (1972) · Science · doi:10.1126/science.177.4054.1104 · Cited by 1,210
Turbidimetric studies of the in vitro assembly and disassembly of porcine neurotubules
Gaskin, F., Cantor, C. R., & Shelanski, M. L. (1974) · Journal of Molecular Biology · doi:10.1016/0022-2836(74)90048-5 · Cited by 816
A theory of linear and helical aggregations of macromolecules
Oosawa, F., & Kasai, M. (1962) · Journal of Molecular Biology · doi:10.1016/s0022-2836(62)80112-0 · Cited by 766
Corliss, J. O., Inoue, S., & Stephens, R. E. (1977) · Transactions of the American Microscopical Society · doi:10.2307/3226119 · Cited by 763
Head to tail polymerization of actin
Wegner, A. (1976) · Journal of Molecular Biology · doi:10.1016/s0022-2836(76)80100-3 · Cited by 707
Opposite end assembly and disassembly of microtubules at steady state in vitro
Margolis, R. L., & Wilson, L. (1978) · Cell · doi:10.1016/0092-8674(78)90132-0 · Cited by 570
Research works printed but not linked: 3
- Schiff, P. B., Fant, J., Auster, L. A. & Horwitz, S. B. J. supramolec. Struct. 8, Suppl. 2, 328 (1978).
- Gaskin, F. & Shelanski, M. L. Essays Biochem. 12, 115–146 (1976).
- Borisy, G. G., Olmstead, J. B., Marcum, J. M. & Allen, C. Fedn Proc. 33, 167–174 (1974).
Cited by
Items 501–600 of 1,008
Ni, D., Lu, S., & Zhang, J. (2019) · Medicinal Research Reviews · doi:10.1002/med.21585 · Cited by 116
Key genes and molecular mechanisms related to Paclitaxel Resistance
Alalawy, A. I. (2024) · Cancer Cell International · doi:10.1186/s12935-024-03415-0 · Cited by 121
“Paclitaxel inhibits the assembly of microtubules and prevents cell division [24].”
BackgroundTumor-Specific Novel Taxoid−Monoclonal Antibody Conjugates
Ojima, I., Geng, X., Wu, X., Qu, C., Borella, C. P., Xie, H., Wilhelm, S. D., Leece, B. A., Bartle, L. M., Goldmacher, V. S., et al. (2002) · Journal of Medicinal Chemistry · doi:10.1021/jm025540g · Cited by 116
Acoustic sensors as a biophysical tool for probing cell attachment and cell/surface interactions
Saitakis, M., & Gizeli, E. (2011) · Cellular and Molecular Life Sciences · doi:10.1007/s00018-011-0854-8 · Cited by 122
Ojima, I. (2004) · ChemBioChem · doi:10.1002/cbic.200300844 · Cited by 116
Chau, M., & Croteau, R. (2004) · Archives of Biochemistry and Biophysics · doi:10.1016/j.abb.2004.04.016 · Cited by 116
Hamel, E., del Campo, A. A., Lowe, M., & Lin, C. M. (1981) · Journal of Biological Chemistry · doi:10.1016/s0021-9258(19)68489-9 · Cited by 116
A novel polymer–paclitaxel conjugate based on amphiphilic triblock copolymer
Xie, Z., Guan, H., Chen, X., Lü, C., Chen, L., Hu, X., Shi, Q., & Jing, X. (2006) · Journal of Controlled Release · doi:10.1016/j.jconrel.2006.11.014 · Cited by 122
“[2–10] that paclitaxel was hailed by National Cancer Institute as the most significant advance in chemotherapy of the 20 years [11].”
MethodTumor Specific Novel Taxoid-Monoclonal Antibody Conjugates
Wu, X., & Ojima, I. (2004) · Current Medicinal Chemistry · doi:10.2174/0929867043455963 · Cited by 115
Song, H., He, R., Wang, K., Ruan, J., Bao, C., Li, N., Ji, J., & Cui, D. (2009) · Biomaterials · doi:10.1016/j.biomaterials.2009.11.067 · Cited by 116
“[26] Schiff P, Horwitz SB.”
BackgroundThe immunopharmacology of paclitaxel (Taxol®), docetaxel (Taxotere®), and related agents
Fitzpatrick, F. A., & Wheeler, R. H. (2003) · International Immunopharmacology · doi:10.1016/j.intimp.2003.08.007 · Cited by 128
Reckzeh, B., Merte, H., Pflüger, K.-H., Pfab, R., Wolf, M., & HAVEMANN, K. (1996) · Journal of Clinical Oncology · doi:10.1200/jco.1996.14.4.1071 · Cited by 115
Morris, J. R., & Lasek, R. J. (1984) · The Journal of cell biology · doi:10.1083/jcb.98.6.2064 · Cited by 113
Schatten, G. P. (1982) · International review of cytology · doi:10.1016/s0074-7696(08)61673-3 · Cited by 116
Total synthesis of the complex taxane diterpene canataxpropellane
Schneider, F., Samarin, K., Zanella, S., & Gaich, T. (2020) · Science · doi:10.1126/science.aay9173 · Cited by 113
New tubulin targeting agents currently in clinical development
Carlson, R. O. (2008) · Expert Opinion on Investigational Drugs · doi:10.1517/13543784.17.5.707 · Cited by 113
“1 Taxanes Following their discovery as cytotoxic agents in the early 1960s [5] , taxanes were subsequently demonstrated to induce microtubule stabilization in 1979 [6] .”
BackgroundUnoki, M., Brunet, J., & Mousli, M. (2009) · Biochemical Pharmacology · doi:10.1016/j.bcp.2009.05.035 · Cited by 113
Mechanisms of Non-Opioid Analgesics Beyond Cyclooxygenase Enzyme Inhibition
Hamza, M., & Dionne, R. (2009) · Current Molecular Pharmacology · doi:10.2174/1874467210902010001 · Cited by 108
Curtin, J. P., Blessing, J. A., Webster, K. D., Rose, P. G., Mayer, A. R., Fowler, W. C., Malfetano, J. H., & Alvarez, R. D. (2001) · Journal of Clinical Oncology · doi:10.1200/jco.2001.19.5.1275 · Cited by 112
miR-135a contributes to paclitaxel resistance in tumor cells both in vitro and in vivo
de Haar-Holleman, A., Chung, I., Olsen, R. R., Kwak, B., Mizokami, A., Saijo, N., Parissenti, A. M., Duan, Z., Voest, E. E., & Zetter, B. R. (2011) · Oncogene · doi:10.1038/onc.2011.148 · Cited by 116
“By stabilizing microtubules and inhibiting their disassembly to tubulin, taxanes interfere with proper formation of the mitotic spindle, which leads to activation of the mitotic spindle checkpoint and mitotic arrest (Schiff et al., 1979).”
Hunt, J. T. (2009) · Molecular Cancer Therapeutics · doi:10.1158/1535-7163.mct-08-0999 · Cited by 105
“Following the original discovery of paclitaxel (1) and the elucidation of its unique mechanism of action as a microtubule-stabilizing agent (2), BMS, working closely with the National Cancer Institute, had developed paclitaxel into a mainstay therapy for breast, non-small cell lung, and other tumors.”
BackgroundInfluentialChemistry and chemical biology of taxane anticancer agents.
Miller, M. L., & Ojima, I. (2001) · The chemical record · doi:10.1002/tcr.1008 · Cited by 108
Hoch, H. C., & Staples, R. C. (1985) · PROTOPLASMA · doi:10.1007/bf01279730 · Cited by 112
Paclitaxel Disposition in Plasma and Central Nervous Systems of Humans and Rats With Brain Tumors
Glantz, M., Choy, H., Kearns, C. M., Mills, P. C., Wahlberg, L. U., Zuhowski, E. G., Calabresi, P. A., & Egorin, M. J. (1995) · JNCI Journal of the National Cancer Institute · doi:10.1093/jnci/87.14.1077 · Cited by 111
Total Synthesis of Eleutherobin
Nicolaou, K. C., van Delft, F. L., Ohshima, T., Vourloumis, D., Xu, J., Hosokawa, S., Pfefferkorn, J. A., Kim, S., & Li, T. (1997) · Angewandte Chemie International Edition in English · doi:10.1002/anie.199725201 · Cited by 111
Mechanism of Methylmercury Cytotoxicity
Miura, K., Imura, N., & Clarkson, T. W. (1987) · Critical Reviews in Toxicology · doi:10.3109/10408448709089860 · Cited by 111
Menendez, J. A., Vellon, L., Colomer, R., & Lupu, R. (2005) · International Journal of Cancer · doi:10.1002/ijc.20754 · Cited by 110
Akt Involvement in Paclitaxel Chemoresistance of Human Ovarian Cancer Cells
KIM, S., Juhnn, Y., & Song, Y. S. (2007) · Annals of the New York Academy of Sciences · doi:10.1196/annals.1397.012 · Cited by 110
Ganesh, T., Guza, R. C., Bane, S., Ravindra, R., Shanker, N., Lakdawala, A. S., Snyder, J., & Kingston, D. (2004) · Proceedings of the National Academy of Sciences of the United States of America · doi:10.1073/pnas.0403459101 · Cited by 97
May, W. S., Sahyoun, N. E., Jacobs, S., Wolf, M., & Cuatrecasas, P. (1985) · Journal of Biological Chemistry · doi:10.1016/s0021-9258(17)39383-3 · Cited by 110
The cytoskeleton as a novel therapeutic target for old neurodegenerative disorders
Eira, J., Silva, C. S., Sousa, M. M., & Liz, M. A. (2016) · Progress in Neurobiology · doi:10.1016/j.pneurobio.2016.04.007 · Cited by 122
Ancient plant-like terpene biosynthesis in corals
Burkhardt, I., de Rond, T., Chen, P. Y.-T., & Moore, B. S. (2022) · Nature Chemical Biology · doi:10.1038/s41589-022-01026-2 · Cited by 100
Enhancing the efficacy of cisplatin in ovarian cancer treatment – could arsenic have a role
Helm, C. W., & States, J. C. (2009) · Journal of Ovarian Research · doi:10.1186/1757-2215-2-2 · Cited by 110
“Paclitaxel and subsequently its cousin, docetaxel were shown to have a unique mechanism of action binding to tubulin polymers (microtubules) and stabilizing the microtubule against depolymerization [29-32].”
BackgroundTetrahedral DNA nanostructures for effective treatment of cancer: advances and prospects
Yan, J., Zhan, X., Zhang, Z., Chen, K., Wang, M., Sun, Y., He, B., & Liang, Y. (2021) · Journal of Nanobiotechnology · doi:10.1186/s12951-021-01164-0 · Cited by 111
“Most chemotherapeutic drugs are fat-soluble cellular drugs with different mechanisms of action, including: (1) affecting the chemical structure of DNA, such as cisplatin [91], (2) inhibition of nucleic acid synthesis, such as DOX and 5-fluorouracil [65, 92]; (3) interfering with DNA replication, such as camptothecin d…”
BackgroundItoh, Y., Suzuki, T., Kouketsu, A., Suzuki, N., Maeda, S., Yoshida, M., Nakagawa, H., & Miyata, N. (2007) · Journal of Medicinal Chemistry · doi:10.1021/jm7009217 · Cited by 104
S-phase specificity of cell killing by docetaxel (Taxotere) in synchronised HeLa cells
Hennequin, C., Giocanti, N., & Favaudon, V. (1995) · British Journal of Cancer · doi:10.1038/bjc.1995.232 · Cited by 117
A Cell-Based High-Content Screening Assay Reveals Activators and Inhibitors of Cancer Cell Invasion
Quintavalle, M., Elia, L., Price, J. H., Heynen‐Genel, S., & Courtneidge, S. A. (2011) · Science Signaling · doi:10.1126/scisignal.2002032 · Cited by 107
“The antitumor effect of paclitaxel is based on its ability to bind and stabilize microtubules and consequently inhibit mitosis and induce apoptosis (26).”
BackgroundProtein Assemblies: Nature-Inspired and Designed Nanostructures
Hamley, I. W. (2019) · Biomacromolecules · doi:10.1021/acs.biomac.9b00228 · Cited by 111
The Seco-Taxane IDN5390 Is Able to Target Class III β-Tubulin and to Overcome Paclitaxel Resistance
Ferlini, C., Raspaglio, G., Mozzetti, S., Cicchillitti, L., Filippetti, F., Gallo, D., Fattorusso, C., Campiani, G., & Scambia, G. (2005) · Cancer Research · doi:10.1158/0008-5472.can-04-3065 · Cited by 115
Wall, M. E., & Banes, A. J. (2005) · PubMed · Cited by 107
Chemical studies of 10-deacetyl baccatin III
Guéritte, F., Sénilh, V., David, B., Guénard, D., & Potìer, P. (1986) · Tetrahedron · doi:10.1016/s0040-4020(01)87285-9 · Cited by 107
Liposomes as Carriers of Cancer Chemotherapy
Kim, S. (1993) · Drugs · doi:10.2165/00003495-199346040-00004 · Cited by 107
“dophyllotoxins, in that paclitaxel promotes microtubule assembly and stabilises tubulin polymer formation (Kumer 1981; Schiff et al. 1979; Schiff & Horowitz 1981).”
BackgroundSekeres, M. J., Bradley-Garcia, M., Martínez-Canabal, A., & Winocur, G. (2021) · International Journal of Molecular Sciences · doi:10.3390/ijms222312697 · Cited by 110
“Paclitaxel (PTX; Taxol), a taxane agent used in breast and other cancer treatment, binds tubulin to hyper-stabilize microtubule polymerization, preventing normal axonal remodeling and transport and ultimately leading to cell death [144,145].”
BackgroundDIFFERENT IN VITRO METABOLISM OF PACLITAXEL AND DOCETAXEL IN HUMANS, RATS, PIGS, AND MINIPIGS
Václavíková, R., Souček, P., Svobodova, L., Anzenbacher, P., Šimek, P., Guengerich, F. P., & Gut, I. (2004) · Drug Metabolism and Disposition · doi:10.1124/dmd.32.6.666 · Cited by 106
“(Schiff et al., 1979), and induce apoptosis (Fan, 1999; Aoudjit and”
BackgroundZaks‐Zilberman, M., Zaks, T. Z., & Vogel, S. N. (2001) · Cytokine · doi:10.1006/cyto.2001.0935 · Cited by 106
Seidman, R., Gitelman, I., Sagi, O., Horwitz, S. B., & Wolfson, M. (2001) · Experimental Cell Research · doi:10.1006/excr.2001.5262 · Cited by 106
Self-citationPaclitaxel chemotherapy for the treatment of gastric cancer
Sakamoto, J., Matsui, T., & Kodera, Y. (2009) · Gastric Cancer · doi:10.1007/s10120-009-0505-z · Cited by 115
Total Synthesis of (−)-Discodermolide: An Application of a Chelation-Controlled Alkylation Reaction
Harried, S. S., Yang, G., Strawn, M. A., & Myles, D. C. (1997) · The Journal of Organic Chemistry · doi:10.1021/jo9708093 · Cited by 106
Choy, H., Safran, H. P., Akerley, W., Graziano, S. L., Bogart, J. A., & Cole, B. F. (1998) · PubMed · Cited by 106
Ferber, S., Tiram, G., Sousa-Herves, A., Eldar-Boock, A., Krivitsky, A., Scomparin, A., Yeini, E., Ofek, P., Ben-Shushan, D., Vossen, L. I., et al. (2017) · eLife · doi:10.7554/elife.25281 · Cited by 102
“This class of drug binds to polymerized tubulin and inhibits the dissociation rate, leading to M phase cell cycle arrest (Schiff et al., 1979).”
BackgroundRegioselective Metabolism of Taxoids by Human CYP3A4 and 2C8: Structure-Activity Relationship
Cresteil, T., Monsarrat, B., Dubois, J., Sonnier, M., Alvinerie, P., & Guéritte, F. (2002) · Drug Metabolism and Disposition · doi:10.1124/dmd.30.4.438 · Cited by 105
“cell cycle in phase G2/M (Wani et al., 1971; Schiff et al., 1979).”
BackgroundSynthesis, Biological Evaluation of 1,1‐Diarylethylenes as a Novel Class of Antimitotic Agents
Hamzé, A., Giraud, A., Messaoudi, S., Provot, O., Peyrat, J., Bignon, J. S., Liu, J., Wdzieczak‐Bakala, J., Thoret, S., Dubois, J., et al. (2009) · ChemMedChem · doi:10.1002/cmdc.200900290 · Cited by 106
Synthesis and biological evaluation of new taxoids derived from 2-deacetoxytaxinine J
Botta, M., Armaroli, S., Castagnolo, D., Fontana, G., Pera, P. J., & Bombardelli, E. (2007) · Bioorganic & Medicinal Chemistry Letters · doi:10.1016/j.bmcl.2006.12.101 · Cited by 105
Gemcitabine and Docetaxel in Metastatic Sarcoma: Past, Present, and Future
Maki, R. G. (2007) · The Oncologist · doi:10.1634/theoncologist.12-8-999 · Cited by 105
“Docetaxel is an agent that stabilizes tubulin, inhibiting the dynamic reorganization of the microtubular network of the cell, resulting in inhibition of mitotic and interphase cellular functions [ 7 , 8]. Besides affecting microtubules (and mitosis in particular), taxanes also appear to have other functions in the tum…”
BackgroundApte, S. M., Fan, D., Killion, J. J., & Fidler, I. J. (2004) · Clinical Cancer Research · doi:10.1158/1078-0432.ccr-1151-3 · Cited by 114
“STI571 inhibits PDGF-mediated PDGF-R activation and, hence, stabilizes microtubules in the target cells, a process similar to paclitaxel’s mechanism of action; that is, paclitaxel promotes microtubule assembly (70).”
BackgroundRegulation of cytoskeletal mechanics and cell growth by myosin light chain phosphorylation
Cai, S., Pestic‐Dragovich, L., O’Donnell, M. E., Wang, N., Ingber, D. E., Elson, E. L., & de Lanerolle, P. (1998) · American Journal of Physiology-Cell Physiology · doi:10.1152/ajpcell.1998.275.5.c1349 · Cited by 109
“Other experiments have shown that stabilizing microtubules blocks mitosis (39) and that inhibiting myosin II activity blocks cytokinesis (10, 26).”
BackgroundMittapalli, R. K., Liu, X., Adkins, C. E., Nounou, M. I., Bohn, K. A., Terrell, T. B., Qhattal, H. S., Geldenhuys, W. J., Palmieri, D., Steeg, P. S., et al. (2013) · Molecular Cancer Therapeutics · doi:10.1158/1535-7163.mct-13-0132 · Cited by 101
“HA-paclitaxel conjugates brain metastatic cells cytotoxicity Paclitaxel acts by binding and stabilizing the microtubules, which ultimately results in a G2-M arrest of the cell-cycle (35, 36).”
Microtubule-Targeting Drugs: More than Antimitotics
Kaul, R., Risinger, A. L., & Mooberry, S. L. (2019) · Journal of Natural Products · doi:10.1021/acs.jnatprod.9b00105 · Cited by 107
Efficacy and Toxicity of Paclitaxel (Taxol) for the Treatment of Canine Malignant Tumors
Poirier, V. J., Hershey, A., Burgess, K. E., Phillips, B. S., Turek, M., Forrest, L. J., Beaver, L., & Vail, D. M. (2004) · Journal of Veterinary Internal Medicine · doi:10.1111/j.1939-1676.2004.tb00164.x · Cited by 104
New Natural Products in Cancer Chemotherapy
Slichenmyer, W. J., & Hoff, D. D. V. (1990) · The Journal of Clinical Pharmacology · doi:10.1002/j.1552-4604.1990.tb01873.x · Cited by 109
Labdane-type diterpenes: Chemistry and biological activity
Demetzos, C., & DIMAS, K. S. (2001) · Studies in natural products chemistry · doi:10.1016/s1572-5995(01)80009-0 · Cited by 103
Clinical trials and progress with paclitaxel in ovarian cancer
Kumar, S., Mahdi, Shah, Garg, Bryant, & Munkarah (2010) · International Journal of Women s Health · doi:10.2147/ijwh.s7012 · Cited by 103
“In 1979, Horwitz et al noted that the drug prevented cell division by promoting the assembly of microtubules without inhibiting their disassembly.(7) In the initial phases, development was slow because paclitaxel did not appear to be more effective than other agents under development, and the procurement of this poten…”
Neurodegenerative diseases linked to misfolded proteins and their therapeutic approaches: A review
Khanam, H., Ali, A., Asif, M., & Shamsuzzaman (2016) · European Journal of Medicinal Chemistry · doi:10.1016/j.ejmech.2016.08.006 · Cited by 108
Taxol (paclitaxel): a novel anti-microtubule agent with remarkable anti-neoplastic activity
Foà, R., Norton, L., & Seidman, A. D. (1994) · International Journal of Clinical & Laboratory Research · doi:10.1007/bf02592403 · Cited by 103
“These researchers demonstrated that Taxol binds preferentially to microtubules and that its binding site is different from that of other anti-microtubule agents, such as colchicine, vinca alkaloids, and podophyllotoxin [4, 7, 8]. In fact, the overall effect of Taxol, that of binding to tubulin and of promoting the ass…”
BackgroundMethodChapin, S. J., & Bulinski, J. C. (1992) · Cell Motility and the Cytoskeleton · doi:10.1002/cm.970230403 · Cited by 115
Marr, J. J., & Docampo, R. (1986) · Clinical Infectious Diseases · doi:10.1093/clinids/8.6.884 · Cited by 103
A Microtubule‐Facilitated Nuclear Import Pathway for Cancer Regulatory Proteins
Roth, D., Moseley, G. W., Glover, D. J., Pouton, C. W., & Jans, D. A. (2007) · Traffic · doi:10.1111/j.1600-0854.2007.00564.x · Cited by 103
“Microtubule dynamics are required for optimal nuclear accumulation of Rb To investigate the MT dependence of Rb nuclear import further, COS-7 cells were transfected to express GFP–Rb, incubated in the presence or absence of the MT-stabilizing agent taxol (23,24) and imaged live 14 h p.”
MethodNicolaou, K. C., Xu, J.-Y., Kim, S., Ohshima, T., Hosokawa, S., & Pfefferkorn, J. A. (1997) · Journal of the American Chemical Society · doi:10.1021/ja973000g · Cited by 102
Schatten, G. P., Schatten, H., Bestor, T. H., & Balczon, R. (1982) · The Journal of Cell Biology · doi:10.1083/jcb.94.2.455 · Cited by 102
Parness, J., Kingston, D. G. I., Powell, R. G., Harracksingh, C., & Horwitz, S. B. (1982) · Biochemical and Biophysical Research Communications · doi:10.1016/0006-291x(82)91080-4 · Cited by 102
Self-citationLiebmann, J., Cook, J. A., Lipschultz, C. A., Teague, D., Fisher, J. M., & Mitchell, J. B. (1994) · Cancer Chemotherapy and Pharmacology · doi:10.1007/bf00685909 · Cited by 102
“Paclitaxel promotes the assembly of microtubules in the absence of microtubule associated proteins and prevents the disaggregation of microtubules that normally occurs at low temperatures or in the presence of low concentrations of calcium [14, 15].”
BackgroundStandart, N., Bray, S. J., George, E. L., Hunt, T., & RUDERMAN, J. V. (1985) · The Journal of Cell Biology · doi:10.1083/jcb.100.6.1968 · Cited by 102
miR-34c may protect lung cancer cells from paclitaxel-induced apoptosis
Catuogno, S., Cerchia, L., Romano, G., Pognonec, P., Condorelli, G., & de Franciscis, V. (2012) · Oncogene · doi:10.1038/onc.2012.51 · Cited by 105
Nanoparticle Albumin-Bound Paclitaxel (Abraxane®)
Desai, N. P. (2016) · Springer eBooks · doi:10.1007/978-981-10-2116-9_6 · Cited by 129
Harshita, Barkat, M. A., Beg, S., Pottoo, F. H., & Ahmad, F. J. (2019) · Nanomedicine · doi:10.2217/nnm-2018-0313 · Cited by 102
Tumor targeting by conjugation of DHA to paclitaxel
Bradley, M. O., Swindell, C. S., Anthony, F. H., Witman, P. A., Devanesan, P. D., Webb, N. L., Baker, S. D., Wolff, A. C., & Donehower, R. C. (2001) · Journal of Controlled Release · doi:10.1016/s0168-3659(01)00321-2 · Cited by 101
Anticancer drug discovery in the future: an evolutionary perspective
Ma, X., & Wang, Z. (2009) · Drug Discovery Today · doi:10.1016/j.drudis.2009.09.006 · Cited by 116
Kohler, D. R., & Goldspiel, B. R. (1994) · Pharmacotherapy: The Journal of Human Pharmacology and Drug Therapy · doi:10.1002/j.1875-9114.1994.tb02785.x · Cited by 98
Mechanism of Action of Cryptophycin
Smith, C. D., & Zhang, X. (1996) · Journal of Biological Chemistry · doi:10.1074/jbc.271.11.6192 · Cited by 111
Taxol, a microtubule stabilizing agent, blocks the replication of Trypanosoma cruzi.
Baum, S. G., Wittner, M., Nadler, J. P., Horwitz, S. B., Dennis, J. E., Schiff, P. B., & Tanowitz, H. B. (1981) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.78.7.4571 · Cited by 101
Self-citationHPLC Separation of Taxol and Cephalomannine
Cardellina, J. H. (1991) · Journal of Liquid Chromatography · doi:10.1080/01483919108049278 · Cited by 101
Removal of .BETA.III Isotype Enhances Taxol Induced Microtubule Assembly.
Lu, Q., & Luduena, R. F. (1993) · Cell Structure and Function · doi:10.1247/csf.18.173 · Cited by 103
Chemical genetics: tailoring tools for cell biology
Mayer, T. U. (2003) · Trends in Cell Biology · doi:10.1016/s0962-8924(03)00077-1 · Cited by 119
Williams, H. J., Scott, A. I., Dieden, R. A., Swindell, C. S., Chirlian, L. E., Francl, M. M., Heerding, J. M., & Krauss, N. E. (1993) · Tetrahedron · doi:10.1016/s0040-4020(01)81823-8 · Cited by 101
Chen, L., Zeng, D., Xu, N., Li, C., Zhang, W., Zhu, X., Gao, Y., Chen, P. R., & Lin, J. (2019) · ACS Applied Materials & Interfaces · doi:10.1021/acsami.9b14046 · Cited by 98
Development of polyploidization in taxol-resistant human leukemia cells in vitro.
Roberts, J. R., Allison, D. C., Donehower, R. C., & Rowinsky, E. K. (1990) · PubMed · Cited by 100
Choy, H., DeVore, R. F., Hande, K. R., Porter, L. L., Rosenblatt, P., Yunus, F., Schlabach, L., Smith, C., Shyr, Y., & Johnson, D. H. (2000) · International Journal of Radiation Oncology*Biology*Physics · doi:10.1016/s0360-3016(00)00420-x · Cited by 100
Yip, K. W., Mao, X., Au, P. Y. B., Hedley, D. W., Chow, S., Dalili, S., Mocanu, J. D., Bastianutto, C., Schimmer, A., & Liu, F.-F. (2006) · Clinical Cancer Research · doi:10.1158/1078-0432.ccr-06-0536 · Cited by 99
Rice, A., Liu, Y., Michaelis, M. L., Himes, R. H., Georg, G. I., & Audus, K. L. (2005) · Journal of Medicinal Chemistry · doi:10.1021/jm040114b · Cited by 106
Preparation and biological activity of taxol acetates
Mellado, W., Magri, N. F., Kingston, D. G. I., Garcia‐Arenas, R., Orr, G. A., & Horwitz, S. B. (1984) · Biochemical and Biophysical Research Communications · doi:10.1016/0006-291x(84)91557-2 · Cited by 99
Self-citationStewart, Z. A., Mays, D. J., & Pietenpol, J. A. (1999) · PubMed · Cited by 121
Bioactive Secondary Metabolites Produced by the Fungal Endophytes of Conifers
Stierle, A. A., & Stierle, D. B. (2015) · Natural Product Communications · doi:10.1177/1934578x1501001012 · Cited by 110
“Although these early results were encouraging, the real turning point in the paclitaxel saga, however, was the discovery of its unique activity as a promoter of tubulin polymerization [14].”
BackgroundPaclitaxel-Based Chemotherapy Targeting Cancer Stem Cells from Mono- to Combination Therapy
Nawara, H. M., Afify, S. M., Hassan, G., Zahra, M. H., Seno, A., & Seno, M. (2021) · Biomedicines · doi:10.3390/biomedicines9050500 · Cited by 105
“The drug reduces the critical dynamics of tubulin required for cell division [20].”
BackgroundInfluentialPassive Mechanical Behavior of Human Neutrophils: Effects of Colchicine and Paclitaxel
Tsai, M. A., Waugh, R. E., & Keng, P. C. (1998) · Biophysical Journal · doi:10.1016/s0006-3495(98)78035-x · Cited by 98
“It promotes tubulin polymerization and stabilizes mi- crotubules from disassembly, thereby resulting in a net increase in cytoskeletal microtubules (Schiff et al., 1979; Manfredi et al., 1982; Rowinsky et al., 1988; Derry et al., 1995).”
BackgroundNab-paclitaxel for the treatment of breast cancer: efficacy, safety, and approval
Yamamoto, Y., Kawano, I., & Iwase (2011) · OncoTargets and Therapy · doi:10.2147/ott.s13836 · Cited by 99
Design, Synthesis, and Biological Evaluation of New-Generation Taxoids
Ojima, I., Chen, J., Sun, L., Borella, C. P., Wang, T., Miller, M. L., Lin, S., Geng, X., Kuznetsova, L., Qu, C., et al. (2008) · Journal of Medicinal Chemistry · doi:10.1021/jm800086e · Cited by 98
“2’-Triisopropyl-3'-dephenyl-3'-(2-methyl-1-propenyl)-7-triethylsilyldocetaxel (5)”
Self-citationHuang, G. S., Brouwer‐Visser, J., Ramirez, M. J., Kim, C. H., Hébert, T. M., Lin, J., Arias‐Pulido, H., Qualls, C., Prossnitz, E. R., Goldberg, G. L., et al. (2010) · Clinical Cancer Research · doi:10.1158/1078-0432.ccr-09-3233 · Cited by 100
Self-citationPark, S. B., Lin, C. S.-Y., Krishnan, A. V., Friedlander, M. L., Lewis, C. R., & Kiernan, M. C. (2010) · Muscle & Nerve · doi:10.1002/mus.21874 · Cited by 107
“Paclitaxel binds to tubulin, inhibits the disassembly of microtubules, and leads to enhanced polymerization and subsequent inhibition of cell division.(1,5,6) More frequent dosing may provide a continuous apoptotic response and lead to improved drug exposure to tumor cells.”
BackgroundNovel cytotoxic drugs: Old challenges, new solutions
Ismael, G., Rosa, D. D., Mano, M. S., & Awada, A. H. (2007) · Cancer Treatment Reviews · doi:10.1016/j.ctrv.2007.08.001 · Cited by 98
Antifungal properties of taxol and various analogues
Young, D. H., MICHELOTTI, E. L., Swindell, C. S., & Krauss, N. E. (1992) · Cellular and Molecular Life Sciences · doi:10.1007/bf02118425 · Cited by 98
Metadata
- Authors
- SCHIFF, P. B., FANT, J., & HORWITZ, S. B.
- Affiliations
- Albert Einstein College of Medicine (US)
- ORCID
- SCHIFF, PETER B.
- Venue
- Nature
- Published
- 1979-02
- Volume
- 277
- Issue
- 5698
- Pages
- 665-667
- ISSN
- 0028-0836 (ISSN-L)
- 1476-4687
- OpenAlex
- W2067299834
- Cited by
- 3,600
- References
- 18
- Citations by year
- 2026: 50 · 2025: 68 · 2024: 72 · 2023: 86 · 2022: 89 · 2021: 93 · 2020: 67 · 2019: 83 · 2018: 84 · 2017: 86 · 2016: 90 · 2015: 99 · 2014: 105 · 2013: 105 · 2012: 102
- FWCI
- 13.01
- Type
- journal article
- Language
- en
- Open access
- closed
- Licence
- www.springer.com/tdm (tdm)
- Locations
- Nature (publishedVersion)
- PubMed (publishedVersion)
- Topics
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Cell Biology › Microtubule and mitosis dynamics
- Health Sciences › Medicine › Oncology › Cancer Treatment and Pharmacology
- Physical Sciences › Chemistry › Organic Chemistry › Heterocyclic Compound Synthesis and Bioactivity
- Keywords
- paclitaxel, microtubule assembly, tubulin, Taxus brevifolia, HeLa cells, cell cycle arrest, G2/M block, antitumour activity, colchicine, podophyllotoxin, microtubule depolymerization, critical concentration
- MeSH terms
- Animals, Antineoplastic Agents, Phytogenic, Calcium, Cattle, Cold Temperature, Glycoproteins, Kinetics, Microtubules, Molecular Weight, Protein Binding, Terpenes, Tubulin, Macromolecular Substances
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.